Medical Condition News

RSS

Telephone support program helps reduce symptoms of caregiver depression, health issues

Rhode Island Hospital researchers have found that a support program administered entirely by telephone can significantly reduce depression and other symptoms in informal caregivers, such as family or friends, of individuals with dementia.

31 Jul 2014

Study shows link between insomnia-related mental health conditions among teens

A study of high school students by University of Adelaide psychology researchers has shed new light on the links between insomnia-related mental health conditions among teens.

31 Jul 2014

Post-doctoral fellows working on stem cell treatment for stroke

The San Antonio Life Sciences Institute, a joint venture between The University of Texas at San Antonio and The University of Texas Health Science Center at San Antonio, has selected the winners of the Postdoc Initiative Pilot Program.

31 Jul 2014

Discovery could lead to development of new cancer therapies

DNA mutations-long known to fuel cancer as well as evolutionary changes in a living organism-had been thought to be rare events that occur randomly throughout the genome.

31 Jul 2014

Chronic obstructive pulmonary disease flare-ups: an interview with Dr. MeiLan Han, University of Michigan and Scott Cerreta, Director of Education, COPD Foundation

During a flare-up, symptoms of a patient’s COPD worsen significantly, and breathing becomes more difficult. A persistent increase in shortness of breath, cough and sputum production are typical symptoms.

30 Jul 2014

Catheter ablation improves quality of life for adults with atrial fibrillation

Adults who undergo a minimally invasive technique to treat atrial fibrillation are significantly less likely to die from a heart attack or heart failure, according to a long-term study by the University of Michigan Frankel Cardiovascular Center.

30 Jul 2014

El Camino Hospital uses Leaf Patient Monitoring system to help prevent hospital-acquired pressure ulcers

El Camino Hospital, a leader in the use of technology to improve patient care, is utilizing the Leaf Patient Monitoring system to help prevent hospital-acquired pressure ulcers by monitoring the position and movement of patients susceptible to bed sores.

30 Jul 2014

EMA CHMP issues positive opinion for label updates to Takeda's Vipidia, Vipdomet and Incresync

Takeda Pharmaceuticals International GmbH today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued positive opinions for updates to the Summary of Product Characteristics (SmPC) for Vipidia (alogliptin) and the fixed-dose combination (FDC) therapies Vipdomet (alogliptin and metformin) and Incresync (alogliptin and pioglitazone).

30 Jul 2014

CardioNova initiates Phase 1b clinical trial with AtheroNova's AHRO-001

AtheroNova Inc., a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announces that its partner, CardioNova, has accomplished first dosing of subjects for its Phase 1b clinical trial with AtheroNova's lead compound, AHRO-001.

30 Jul 2014

More accurate tests could be created to diagnose memory problems

UEA research finds hope for more accurate diagnosis of memory problems. More accurate tests could be created to diagnose diseases such as Alzheimer's or memory problems stemming from head injuries, leading to earlier intervention, according to new findings from the University of East Anglia (UEA).

30 Jul 2014

New anesthesia procedure demonstrates cause of obstruction in patients with severe sleep apnea

A simplified anesthesia procedure may enable more widespread use of preoperative testing to demonstrate the cause of airway obstruction in patients with severe sleep apnea, suggests a study in Anesthesia & Analgesia.

30 Jul 2014

Researchers establish new strategy to help surgeons see entire tumor in patient

The best way to cure most cases of cancer is to surgically remove the tumor. The Achilles heel of this approach, however, is that the surgeon may fail to extract the entire tumor, leading to a local recurrence.

30 Jul 2014

Running for just 10 minutes a day can reduce risk of death

Need an incentive to lace up your shoes and go for a run? A new Iowa State University study, published in the Journal of the American College of Cardiology, found running for just five or 10 minutes a day can significantly reduce your risk of death from cardiovascular disease.

30 Jul 2014

Researchers investigate hereditary breast cancer to find new treatment approaches

Deborah Kelly and Zhi Sheng, assistant professors at the Virginia Tech Carilion Research Institute, recently received a grant from the Commonwealth Health Research Board to investigate hereditary breast cancer, an effort that may lead to new treatment approaches.

30 Jul 2014

Brains of autistic kids are relatively inflexible at switching from rest to task performance

The brains of children with autism are relatively inflexible at switching from rest to task performance, according to a new brain-imaging study from the Stanford University School of Medicine.

30 Jul 2014

EMD Serono begins MSB0010718C Phase II study in mMCC patients

EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, today announced the initiation of an international Phase II study designed to assess the efficacy and safety of MSB0010718C, an investigational fully human IgG1 monoclonal antibody that binds to programmed death-ligand 1 (PD-L1).

29 Jul 2014

GSK announces availability of once-weekly Tanzeum in pharmacies throughout the U.S.

GSK today announced that once-weekly Tanzeum (albiglutide), a prescription injectable treatment for type 2 diabetes in adults, as an adjunct to diet and exercise, is now available in pharmacies throughout the U.S.

29 Jul 2014

FDA approves EYLEA Injection for treatment of Diabetic Macular Edema

Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved EYLEA (aflibercept) Injection for the treatment of Diabetic Macular Edema (DME).

29 Jul 2014

FDA approves use of Imbruvica to treat patients with chronic lymphocytic leukemia

The U.S. Food and Drug Administration today expanded the approved use of Imbruvica (ibrutinib) to treat patients with chronic lymphocytic leukemia (CLL) who carry a deletion in chromosome 17 (17p deletion), which is associated with poor responses to standard treatment for CLL. Imbruvica received a breakthrough therapy designation for this use.

29 Jul 2014

Researchers find molecule that irreversibly interferes with activity of mutated cancer gene

UT Southwestern Medical Center cancer researchers have found a molecule that selectively and irreversibly interferes with the activity of a mutated cancer gene common in 30 percent of tumors.

29 Jul 2014

Medical Condition News

Telephone support program helps reduce symptoms of caregiver depression, health issues

Study shows link between insomnia-related mental health conditions among teens

Post-doctoral fellows working on stem cell treatment for stroke

Discovery could lead to development of new cancer therapies

Chronic obstructive pulmonary disease flare-ups: an interview with Dr. MeiLan Han, University of Michigan and Scott Cerreta, Director of Education, COPD Foundation

Catheter ablation improves quality of life for adults with atrial fibrillation

El Camino Hospital uses Leaf Patient Monitoring system to help prevent hospital-acquired pressure ulcers

EMA CHMP issues positive opinion for label updates to Takeda's Vipidia, Vipdomet and Incresync

CardioNova initiates Phase 1b clinical trial with AtheroNova's AHRO-001

More accurate tests could be created to diagnose memory problems

New anesthesia procedure demonstrates cause of obstruction in patients with severe sleep apnea

Researchers establish new strategy to help surgeons see entire tumor in patient

Running for just 10 minutes a day can reduce risk of death

Researchers investigate hereditary breast cancer to find new treatment approaches

Brains of autistic kids are relatively inflexible at switching from rest to task performance

EMD Serono begins MSB0010718C Phase II study in mMCC patients

GSK announces availability of once-weekly Tanzeum in pharmacies throughout the U.S.

FDA approves EYLEA Injection for treatment of Diabetic Macular Edema

FDA approves use of Imbruvica to treat patients with chronic lymphocytic leukemia

Researchers find molecule that irreversibly interferes with activity of mutated cancer gene

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Latest News